High Court rejects Nurofen tablet manufacturer’s appeal against $6 million penalty

High Court rejects Nurofen tablet manufacturer’s appeal against $6 million penalty

The High Court’s decision to uphold the $6 million penalty against Reckitt Benckiser (Australia) Pty Ltd, the manufacturer of Nurofen tablets, serves as an important reminder for traders to ensure all claims made in their marketing and advertising materials do not extend beyond the capabilities of the goods and services they provide. In particular, the Australian Competition and Consumer Commission has stated its intention to target large companies that engage in misleading or deceptive conduct towards consumers, and to continue to advocate for higher penalties under the Australian Consumer Law. Considering this, we strongly recommend all such companies review and consider the accuracy of their marketing and promotional materials.

Thanks to Kelly Dickson for this update – http://www.mk.com.au/our-people/kelly-dickson/

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s